AC 45594

CAS No. 13037-86-0

AC 45594( 4-Heptyloxyphenol )

Catalog No. M20916 CAS No. 13037-86-0

AC 45594 is an agonist of steroidogenic factor 1 (SF-1) ( IC50 : 50-100 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 28 In Stock
200MG Get Quote In Stock
500MG 63 In Stock
1G 100 In Stock

Biological Information

  • Product Name
    AC 45594
  • Note
    Research use only, not for human use.
  • Brief Description
    AC 45594 is an agonist of steroidogenic factor 1 (SF-1) ( IC50 : 50-100 nM).
  • Description
    AC 45594 is an agonist of steroidogenic factor 1 (SF-1) ( IC50 : 50-100 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-Heptyloxyphenol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    steroidogenic factor 1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13037-86-0
  • Formula Weight
    208.3
  • Molecular Formula
    C13H20O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (480.08 mM)
  • SMILES
    CCCCCCCOc1ccc(O)cc1
  • Chemical Name
    4-(heptyloxy)phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mlynarczuk J Wrobel M H Kotwica J . The orphan nuclear receptor SF-1 is involved in the effect of PCBs DDT and DDE on the secretion of steroid hormones and oxytocin from bovine luteal cells during the estrous cycle in?vitro[J]. Theriogenology 2014 81(7):877-886.
molnova catalog
related products
  • EZH2-IN-2

    EZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity.

  • (6,7-dimethoxyisoqui...

    (6,7-dimethoxyisoquinolin-1-yl)(4-methoxyphenyl)methanone

  • GRF (ovine, caprine)

    GHRF, ovine is a growth hormone-releasing factor. GHRF is a specific mediator for the effects of hypoglycemia upon the release of pituitary growth hormone (GH).